Avacta Group (AVCT)

 

AVCT Share PerformanceMore

52 week high110.00 10/08/16
52 week low60.00 31/03/17
52 week change -11.00 (-10.23%)
4 week volume826,945 01/05/17

Media for (AVCT)

Presenter: Dr. Alastair Smith
01/08/2014
Presenter: Dr. Alastair Smith
07/05/2014

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

2 Biotech's Licence Affimers for Research Use

RNS Number: 7379F Avacta Group PLC 22 May 2017 22 May 2017 Avacta Group plc ("Avacta" or "the Group" or "the Company") Two US biotech companies licence Affimer reagents for research use Exclusive licence deals follow successful custom Affimer evaluations Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagen...

Avacta to be granted patent in China

Avacta Group has announced that the principal patent protecting the Affimer technology had been accepted for grant in C...

Moderna releases Phase I trial data for mRNA technology

Avacta Group has confirmed that Moderna has disclosed Phase I trial data for its mRNA technology. It says this is the firs...

Hardman Research: De-risking Moderna's partnership

RNS Number: 4860E Avacta Group PLC 08 May 2017 Hardman Research: De-risking of the partnership with Moderna De-risking of the partnership with Moderna: Avacta is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a radical alternative to established antibody tech...

Avacta CEO to present at Hardman forum

Avacta Group chief executive Alastair Smith will be presenting at the Hardman Private Investor Forum in London at the ...

Presenting at the Hardman Private Investor Forum

RNS Number: 2489E Avacta Group PLC 05 May 2017 5 May 2017 Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta to Present at the Hardman Private Investor Forum Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagents, is pleased to announce that its Chief Executive, Alastair Smith, will be presentin...

Avacta to Present at BioTrinity 2017

RNS Number: 7905D Avacta Group PLC 02 May 2017 2 May 2017 Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta to Present at BioTrinity 2017 Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagents, is pleased to announce that its Chief Executive, Alastair Smith, will be presenting at BioTrinity 2017, E...

Avacta agrees exclusive deal with global diagnostics firm

Avacta Group has confirmed that an evaluation of its Affimer technology by a large, global diagnostics developer has con...

Fundamental DataMore

EPS-6.86
Dividend yield0 %

Equity Research (AVCT)

hardman & co
Avacta Group Plc
24/05/2017
Avacta is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a radical alternative to established antibody...
hardman & co
Avacta Group Plc
08/05/2017
Avacta is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a radical alternative to established antibody...
hardman & co
Avacta Group Plc
12/04/2017
Avacta is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a radical alternative to established antibody...

Latest discussion posts More

  • Re: 3% shareholders

    as at 25 May 2017 Current significant shareholders are as follows: IP Group plc ? 24.8%
 Henderson Global Investors ? 11.5%
 Aviva 9.6% 
Baillie Gifford & Co Limited ? ...
    25-May-2017
    mol42
  • Re: Hardman 240517

    btw i know today is 23rd! available tonight ahead of schedule tomorrow bw all mol
    23-May-2017
    mol42
  • Hardman 240517

    http://www.hardmanandco.com/docs/default-source/company-docs/avacta-documents/avct---licensing-deal-24-may-2017.pdf mol
    23-May-2017
    mol42

Users' HoldingsMore

Users who hold Avacta Group also hold..
LLOYDS GRP.21%
ROCKHOPPER16%
BARCLAYS12%
ROYAL BANK SCOT11%
AFC ENERGY11%

Codes & Symbols

ISINGB00BYYW9G87
SymbolsAVCT, LSE:AVCT, AVCT.L, AVCT:LN, LON:AVCT, XLON:AVCT